EUVIMEDEUVIMED entdecken
Crossref

L26/P-175 Polarized light microscopy as a promising tool to optimize outcomes in poor-prognosis reproductive patients

J. Aibar Manero, D. Gonzalez Abreu, M. Marti vilanova, M. Escriba Suarez, M. Alavés Navarro, M. Lozano Zamora, V. Lopez martinez, A. Garcia esteve, C. Miret lucio, M. Benavent martinez, J. Teruel lopez, J. Crespo simó

Human Reproduction · 01.07.2026 · 41 (Supplement_1)

DOI: 10.1093/humrep/deag083.511 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von J. Aibar Manero und 11 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Study question Does meiotic spindle visualization during intracytoplasmic sperm injection (ICSI) reduce oocyte damage and improve embryological and clinical outcomes in patients with low ovarian reserves? Summary answer Polarized light microscopy (PLM) enables accurate meiotic spindle visualization, allowing safer ICSI orientation and potentially improving efficiency and outcomes among patients with diminished ovarian reserves. What is known already Advanced maternal age has increased the use of assisted reproductive technologies, particularly among patients with low ovarian reserve, who experience poorer reproductive outcomes. Intracytoplasmic sperm injection (ICSI) is widely used, yet incorrect injections relative to the meiotic spindle may cause mechanical damage, compromising fertilization and embryo development. PLM is a non-invasive technique that visualizes birefringent structures such as the meiotic spindle and zona pellucida without affecting oocyte viability. Accurate spindle localization may help optimize injection strategy and reduce oocyte damage, potentially enhancing reproductive efficiency. Study design, size, duration A prospective single-center study was conducted between January and December 2025, approved by the Bioethics Committee of Clinic hospital (Valencia, Spain). A total of 272 patients undergoing assisted reproductive techniques (ART) with ≤3 metaphase II oocytes and age ≤45 years old were included. Cases with severe male factor infertility (<2 million/mL, <10% progressive motility), vitrified oocytes, and oocyte maturity rates <50% were excluded. Participants/materials, setting, methods In the study group (LP, n = 573 oocytes). PLM was used during ICSI to identify the metaphase plate. The oocyte was repositioned according to meiotic spindle location to avoid damage during microinjection, and each injected oocyte was subsequently tracked. The control group (Cnt) included 352 patients treated at the same center in 2024 meeting identical inclusion criteria (n = 752 oocytes). The mean age in the LP and control groups was 37.9±2.7 and 37.5±3.2 years old, respectively (p = 0.53). Main results and the role of chance The comparative analysis of in vitro outcomes between groups revealed no significant differences in fertilization rates (presence of two pronuclei. LP: 77.1% vs. Cnt: 78.3%; p = 0.64) or in atypical fertilization rates (presence of an abnormal number of pronuclei. LP: 5.76% vs. Cnt: 5.98%; p = 0.86). Nevertheless, the LP group exhibited a higher embryonic culture yield, as indicated by a slightly increased proportion of viable embryos (LP: 65.0% vs. Cnt: 61.3%; p = 0.24). Moreover, the LP cohort demonstrated a superior ratio of embryos classified as high quality according to the Gardner grading system (grades A and B; LP: 83.4% vs. Cnt: 76.4%; p = 0.04) and a lower proportion of poor-quality embryos (grade C; LP: 16.6% vs. Cnt: 23.6%; p = 0.04). Regarding clinical outcomes, 34 embryo transfers were performed, to date, in the LP group compared to 88 in the control group. No significant differences were observed in positive pregnancy rates (LP: 65.9% vs. Cnt: 61.8%; p = 0.68) or clinical pregnancy rates (LP: 55.6% vs. Cnt: 57.0%; p = 0.67). Limitations, reasons for caution Continued follow-up of the cases under investigation is warranted to increase the number of embryo transfers and consequently, achieve more robust and reliable clinical outcomes.This study was conducted in a selected population with compromised reproductive potential. The findings may not be directly extrapolated to populations with an intrinsically favorable prognosis Wider implications of the findings Strategies aimed at minimizing technical disruption of structural organization during ICSI may have relevant clinical relevance. Our results indicate a trend toward higher viable embryo rates and significantly improved quality, supporting PLM as a useful, non-invasive tool to prevent inadvertent meiotic spindle damage, optimizing ART outcomes in complex clinical settings. Trial registration number No

Zitieren

APA

Manero, J. A., Abreu, D. G., vilanova, M. M., Suarez, M. E., Navarro, M. A., Zamora, M. L., martinez, V. L., esteve, A. G., lucio, C. M., martinez, M. B., lopez, J. T., & simó, J. C. (2026). L26/P-175 Polarized light microscopy as a promising tool to optimize outcomes in poor-prognosis reproductive patients. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.511

Vancouver

Manero JA, Abreu DG, vilanova MM, Suarez ME, Navarro MA, Zamora ML, et al. L26/P-175 Polarized light microscopy as a promising tool to optimize outcomes in poor-prognosis reproductive patients. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.511

BibTeX
@article{Manero2026,
  author = {Manero, J. Aibar and Abreu, D. Gonzalez and vilanova, M. Marti and Suarez, M. Escriba and Navarro, M. Alavés and Zamora, M. Lozano and martinez, V. Lopez and esteve, A. Garcia and lucio, C. Miret and martinez, M. Benavent and lopez, J. Teruel and simó, J. Crespo},
  title = {L26/P-175 Polarized light microscopy as a promising tool to optimize outcomes in poor-prognosis reproductive patients},
  journal = {Human Reproduction},
  year = {2026},
  volume = {41},
  number = {Supplement_1},
  doi = {10.1093/humrep/deag083.511}
}
Kostenlos starten →